Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gui Lu Bu Shen Pian is a traditional Chinese medicine (TCM) oral tablet developed and manufactured by Guangdong Xinbao Pharmaceutical. Formulated to address 'Kidney Yang deficiency' and 'Kidney Yin deficiency,' it is primarily used to tonify the kidneys, replenish essence (Jing), and strengthen bones and muscles. The preparation typically incorporates animal-derived glues, such as tortoise-shell glue (*Colla Carapacis et Plastri Testudinis*) and deer antler glue (*Cornu Cervi Pantotrichum*), alongside herbal extracts like prepared Rehmannia root and Goji berry. It is clinically indicated for symptoms including lower back pain, weakness in the limbs, dizziness, tinnitus, and sexual dysfunction such as impotence or spermatorrhea. In the context of TCM, it works by balancing the body's internal Yin and Yang and nourishing the vital essence stored in the kidneys.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gui Lu Bu Shen Pian.